Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07408115 · ClinicalTrials.gov registry record · NA
Herbal Dietary Supplementation on Vasomotor Symptoms in Menopausal Women
A NA study of Hot Flashes and Vasomotor Symptoms, sponsored by Bonafide Health.
- Completed
- Registry status
- NA
- Development phase
- 112
- Enrollment target
- 1
- Study location
NCT07408115: Completed NA study of Hot Flashes and Vasomotor Symptoms, sponsored by Bonafide Health.
NCT07408115 is a NA study of Hot Flashes and Vasomotor Symptoms that has completed, run by Bonafide Health. The registered enrollment target is 112 participants, below the 167-participant average among 23 other Hot Flashes trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07408115, a NA study of Hot Flashes and Vasomotor Symptoms, has completed, sponsored by Bonafide Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 112 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to evaluate the efficacy of a neurokinin 1,3 antagonist on improving vasomotor symptoms (VMS) and overall menopause symptoms in women between the ages of 40-70. The primary research question is whether taking the study product daily for 4 weeks with an optional 8 week extension, significantly reduces the severity and frequency of menopause-related symptoms.
Primary Outcome
Study diary will be completed by participants daily from Day -7 to -1 to establish a pre-dose baseline and then from Day 1 to Day 28 ± for the initial study duration. If a participant participates in the optional extension, they will be asked to continue completing the diaries for an additional 56 ± 3 days, for a total of 84 ± 3 days. The information recorded will be the number and severity of hot flashes that occurred, the number of night sweats and severity, any changes in concomitant medicati
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT JDS-HF3.0
Study Locations (1)
New York
- Bonafide Health - Harrison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2024-05-24 |
| Est. Completion | 2024-12-18 |
| Phase | NA |
What the finished NCT07408115 record still lists
NCT07408115 is an interventional study that assigns participants to a tested intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap, below the 167-participant average among 23 other Hot Flashes trials with a reported enrollment target (33% lower).
The record links to 9 conditions, with Hot Flashes appearing as the primary indexed condition, and to 1 intervention - of which JDS-HF3.0 is the first listed.
NCT07408115 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07408115 about?
NCT07408115 is a clinical study titled "Herbal Dietary Supplementation on Vasomotor Symptoms in Menopausal Women". The goal of this study is to evaluate the efficacy of a neurokinin 1,3 antagonist on improving vasomotor symptoms (VMS) and overall menopause symptoms in women between the ages of 40-70. The primary research question is whether taking the study product daily for 4 weeks with an optional 8 week exten...
What is the current status of trial NCT07408115?
This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2024-05-24. Estimated completion is 2024-12-18.
What conditions does trial NCT07408115 study?
This clinical trial studies the following conditions: Hot Flashes, Vasomotor Symptoms, Night Sweats, Hot Flushes, Hot Flash.
What interventions are being tested in trial NCT07408115?
The interventions under investigation include: JDS-HF3.0 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07408115?
This trial is sponsored by Bonafide Health, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07408115 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hot Flashes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07408115's enrollment target sits among peer trials
112 9th of 23 higher than 13 of 23 other Hot Flashes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hot Flashes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Men With Prostate Cancer: Optimizing Wellness by Enhanced Relief From Hot Flashes With Acupuncture
RECRUITING · NA
-
Hot Flashes and Neurovascular Function in Women
RECRUITING · NA
-
JDS-HF3.0 Supplementation on Menopause Related Quality of Life Outcomes in Postmenopausal Women
RECRUITING · NA
-
Efficacy and Safety of Shatavari for Treatment of Menopausal Symptoms in Women: A Randomized, Double-blind, Three-arm, Parallel, Placebo-controlled Study
RECRUITING · NA
-
Improving Sympathetic Activity, Hot Flashes, and Sleep in Midlife Women Using Inspiratory Muscle Strength Training
RECRUITING · NA
-
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04511013 · 112 participants · Phase 2
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- NCT04551560 · 112 participants · NA
Stress and Congestive Heart Failure
- NCT04872166 · 112 participants · Phase 1
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
- NCT05024773 · 112 participants · Phase 3
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI